Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Aims: To summarize and critically evaluate the effectiveness of psychological and pharmacological interventions for depression in patients with both diabetes and depression. Methods: Randomized controlled trials investigating psychological and pharmacological interventions for depression in adults with diabetes and depression were included. A comprehensive search of primary studies according to Cochrane were conducted. Primary outcomes were depression and glycaemic control. Further, treatment adherence, diabetes complications, mortality, healthcare costs and quality of life were investigated. Two reviewers identified primary studies and extracted data independently. Random‐effects model meta‐analyses were conducted to compute overall estimates of treatment outcomes. Results: The database search resulted in 3963 references, of which 19 trials were included. Randomized controlled trials of psychological interventions showed positive effects on short‐ and medium‐term depression severity [standardized mean difference short‐term range –1.47; –0.14, n = 7; medium‐term standardized mean difference –0.42 (95% CI –0.70 to –0.14), n = 3] and depression remission [odds ratio short term 2.88 (95% CI 1.58–5.25), n = 4; odds ratio medium term 2.49 (95% CI 1.44–4.32), n = 2]. Effects on glycaemic control in psychological intervention trials varied substantially (standardized mean difference range –0.97 to 0.47, n = 4). Selective serotonin reuptake inhibitors showed a moderate beneficial effect on short‐term depression severity [standardized mean difference –0.39 (95% CI –0.64 to –0.13], n = 5) and depression remission [odds ratio 2.52 (95% CI 1.11–5.75), n = 2]. Glycaemic control improved in randomized controlled trials comparing selective serotonin reuptake inhibitors with placebo at the end of treatment [standardized mean difference –0.38 (95% CI –0.64 to –0.12), n = 5]. Conclusions: Psychological and pharmacological interventions positively affect depression outcomes in patients with diabetes at the end of treatment. Furthermore, short‐term glycaemic control improved moderately in pharmacological trials. Most outcomes have not been investigated sufficiently. Moreover, there is a lack of follow‐up data for pharmacological trials limiting the evidence on the sustainability of treatment effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799
Collaborative care for patients with depression and chronic illnesses
Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003955 · Cited by 1,697
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465
Epidemiology of depression and diabetes: a systematic review
Roy, T., & Lloyd, C. E. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70004-6 · Cited by 1,229
Egede, L. E., Zheng, D., & Simpson, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.464 · Cited by 816
The Association of Comorbid Depression With Mortality in Patients With Type 2 Diabetes
Katon, W. J., Rutter, C., Simon, G., Lin, E. H. B., Ludman, E., Ciechanowski, P., Kinder, L., Young, B., & Von Korff, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2668 · Cited by 640
Cited by
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Nouwen, A., Adriaanse, M. C., van Dam, K., Iversen, M. M., Viechtbauer, W., Peyrot, M., Caramlau, I., Kokoszka, A., Kanc, K., de Groot, M., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14054 · Cited by 301
Frailty, Sarcopenia and Diabetes
Morley, J. E., Malmstrom, T. K., Rodriguez-Mañas, L., & Sinclair, A. J. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.001 · Cited by 277
Robinson, D. J., Coons, M., Haensel, H., Vallis, M., & Yale, J.-F. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.031 · Cited by 209
Depression and diabetes: Treatment and health-care delivery
Petrak, F., Baumeister, H., Skinner, T. C., Brown, A., & Holt, R. I. G. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00045-5 · Cited by 166
Self-citationvan der Feltz‐Cornelis, C., Allen, S. F., Holt, R. I. G., Roberts, R., Nouwen, A., & Sartorius, N. (2021) · Brain and Behavior · doi:10.1002/brb3.1981 · Cited by 130
“In order to optimize health outcomes, feasible and effective interventions aiming to provide benefits to both physical and mental health are recommended (Baumeister & Bengel, 2012; Baumeister et al., 2014; Harkness et al., 2010).”
BackgroundTully, P. J., & Baumeister, H. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009128 · Cited by 120
Self-citationLi, C., Xu, D., Hu, M., Tan, Y., Zhang, P., Li, G., & Chen, L. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.02.006 · Cited by 90
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
Pouwer, F., Schram, M. T., Iversen, M. M., Nouwen, A., & Holt, R. I. G. (2020) · Diabetic Medicine · doi:10.1111/dme.14227 · Cited by 70
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
Mikocka-Walus, A., Prady, S. L., Pollok, J., Esterman, A. J., Gordon, A. L., Knowles, S., & Andrews, J. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012680.pub2 · Cited by 59
Tharmaraja, T., Stahl, D., Hopkins, C. W. P., Persaud, S. J., Jones, P. M., Ismail, K., & Moulton, C. D. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000707 · Cited by 35
Metadata
- Authors
- Baumeister, H., Hutter, N., & Bengel, J.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2014-06-18
- Volume
- 31
- Issue
- 7
- Pages
- 773-786
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1999581342
- Cited by
- 113
- References
- 26
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.